Dubbed Elsa, the tool was expected to roll out at the end of June. The FDA says it marks the dawn of a new era. Reading time 2 minutes Generative artificial intelligence has found another home in the ...
AI woes continue, and the US Food and Drug Agency (FDA) faces the same problem with "Elsa," their latest generative AI tool, which allegedly hallucinates information and misinterprets real studies.
Why it matters: It was only a matter of time before governments jumped aboard the AI hype train. The US government has a lousy track record when it comes to rolling out tech projects – remember the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results